National Health Act 1953 Amendment special arrangements under subsection 100(1) Chemotherapy Pharmaceuticals Access Program (No. PB 67 of 2008) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 67 of 2008

Amendment special arrangements under subsection 100(1) of the National Health Act 1953

I, ANDREW MITCHELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.

Dated                             3 JUNE   2008

ANDREW MITCHELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program

1              Commencement

This instrument commences on 1 July 2008.

2              Amendment of PB 93 of 2007

Schedule 1 amends PB 93 of 2007.

Schedule 1        Amendments

[1]            Schedule 2, in all instances where Hospira Australia Pty Ltd appears in the column headed “Brand”

omit:

Hospira Australia Pty Ltd

and substitute:

Hospira Pty Limited

[2]            Schedule 2, items dealing with Folinic acid

omit from the column headed “Brand” (wherever occurring):

LeucovorinCalcium (Hospira Australia Pty Ltd)

and substitute:

Leucovorin Calcium (Hospira Pty Limited)

[3]            Schedule 4, item dealing with Bleomycin

omit from the column headed “Brand”:

Hospira Australia Pty Ltd

and substitute:

Hospira Pty Limited

[4]            Schedule 4, item dealing with Folinic acid in the form Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL

omit from the column headed “Brand”:

LeucovorinCalcium (Hospira Australia Pty Ltd)

and substitute:

Leucovorin Calcium (Hospira Pty Limited)